LGC Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:LGC Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10310
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scientific, genotyping chemistry, genotyping instruments, genotyping libraries and others. It offers services such as genotyping, consultancy, consumer product testing, digital forensic investigation, DNA and RNA extraction services, DNA sequencing, drug and alcohol testing, drug development services, food and agricultural analytical services and others. The company caters to agrigenomics, forensic science, food, government and academia; human genomics, pharma and healthcare and sports sectors. It serves its clients in the UK and abroad. LGC is headquartered in Teddington, the UK.

LGC Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
LGC Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
LGC Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
LGC Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
LGC Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
LGC Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
LGC Ltd, Medical Equipment, Deal Details 11
Venture Financing 11
Lucigen Raises USD2.2 Million in Venture Financing 11
Private Equity 12
KKR to Acquire LGC from Bridgepoint 12
Partnerships 13
Biosearch Technologies Enters into Licensing Agreement with Co-Diagnostics 13
Biosearch Enters into Licensing Agreement with Co-Diagnostics 14
Applied BioCode Enters Into Licensing Agreement With Douglas Scientific For Barcoded Magnetic Beads Technology 15
Lucigen Enters into Distribution Agreement with Illumina 16
SYGNIS Enters into Distribution Agreement with Lucigen 17
Sigma-Aldrich Enters into Distribution Agreement with LGC 18
Lucigen Enters into Agreement with Thermo Fisher Scientific 19
LGC Genomics And Covaris Enter Into Co-Development Agreement For Extraction Of Nucleic Acids 20
Lucigen Enters Into Distribution Agreement With Research Corporation Technologies For Endotoxin Free CleanColi Expression System 21
Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA 22
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 23
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 24
Acquisition 25
LGC Acquires Lucigen 25
LGC Acquires LINK Technologies 26
LGC Acquires Majority Stake in Douglas Scientific from Kingdom Enterprises 27
Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics 28
Biosearch Technologies Acquires DNA Technology 29
LGC Ltd – Key Competitors 30
LGC Ltd – Key Employees 31
LGC Ltd – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 34
Strategy And Business Planning 34
Nov 23, 2017: LGC expands Fordham site to bolster Bioanalytical and CMC capacity 34
Corporate Communications 35
Sep 22, 2017: Dr. Juergen Mueller joins LGC as Commercial and Strategic Development Director, Oligo-therapeutics 35
Product News 36
Sep 18, 2018: LGC announces VALIDATE hsTnT kit for easier linearity and calibration verification on Roche cobas analyzers 36
Mar 30, 2017: LGC announces the addition of a new immunosuppressant certified reference material to its portfolio: pure tacrolimus (ERM-AC022a) 37
Other Significant Developments 38
Jul 31, 2018: NML one of first laboratories to install new TOFWERK instrument 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
LGC Ltd, Medical Equipment, Key Facts, 2017 2
LGC Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
LGC Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
LGC Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
LGC Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
LGC Ltd, Deals By Market, 2012 to YTD 2018 9
LGC Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Lucigen Raises USD2.2 Million in Venture Financing 11
KKR to Acquire LGC from Bridgepoint 12
Biosearch Technologies Enters into Licensing Agreement with Co-Diagnostics 13
Biosearch Enters into Licensing Agreement with Co-Diagnostics 14
Applied BioCode Enters Into Licensing Agreement With Douglas Scientific For Barcoded Magnetic Beads Technology 15
Lucigen Enters into Distribution Agreement with Illumina 16
SYGNIS Enters into Distribution Agreement with Lucigen 17
Sigma-Aldrich Enters into Distribution Agreement with LGC 18
Lucigen Enters into Agreement with Thermo Fisher Scientific 19
LGC Genomics And Covaris Enter Into Co-Development Agreement For Extraction Of Nucleic Acids 20
Lucigen Enters Into Distribution Agreement With Research Corporation Technologies For Endotoxin Free CleanColi Expression System 21
Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA 22
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 23
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 24
LGC Acquires Lucigen 25
LGC Acquires LINK Technologies 26
LGC Acquires Majority Stake in Douglas Scientific from Kingdom Enterprises 27
Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics 28
Biosearch Technologies Acquires DNA Technology 29
LGC Ltd, Key Competitors 30
LGC Ltd, Key Employees 31
LGC Ltd, Other Locations 32
LGC Ltd, Subsidiaries 32
LGC Ltd, Joint Venture 33

List of Figures
LGC Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
LGC Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
LGC Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
LGC Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
LGC Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
LGC Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
LGC Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
LGC Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[LGC Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emerald Resources NL (EMR):石油・ガス:M&Aディール及び事業提携情報
    Summary Emerald Resources NL (Emerald) is an oil and gas company that carries out mineral exploration and development. The company carries out acquisition, exploration, development and produces oil and natural gas, and gold deposits. Its projects include Okavu Gold project, and Magoffin County proje …
  • JenaValve Technology Inc:医療機器:M&Aディール及び事業提携情報
    Summary JenaValve Technology Inc (JenaValve Technology), a subsidiary of JenaValve Technology GmbH, is a medical device company that develops and manufactures transcatheter aortic valve replacement (TAVR) systems for transapical and transfemoral implantation. The company’s TAVR system is an investig …
  • Royal Boskalis Westminster NV:企業のM&A・事業提携・投資動向
    Royal Boskalis Westminster NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal Boskalis Westminster NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • TVEL Fuel Company:企業の戦略的SWOT分析
    TVEL Fuel Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Iwatani Corporation (8088):企業の財務・戦略的SWOT分析
    Iwatani Corporation (8088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Zuger Kantonalbank AG:企業の戦略・SWOT・財務分析
    Zuger Kantonalbank AG - Strategy, SWOT and Corporate Finance Report Summary Zuger Kantonalbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dakota Valley Electric Cooperative:企業の戦略的SWOT分析
    Dakota Valley Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Samyang Biopharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Samyang Biopharmaceuticals Corp (Samyang Biopharm) researches and develops technology platforms for drug delivery. Its product portfolio comprises transdermal patches, injections, ORC hemostat and others. The company spans its expertise in the development and distribution of biodegradable, s …
  • Addnode Group AB (ANOD B):企業の財務・戦略的SWOT分析
    Summary Addnode Group AB (Addnode) is an information technology company that supplies software and services for construction, design, and product data information. The company's solutions include design management solutions, process management solutions, and product lifecycle management solutions, a …
  • Gulf Pharmaceutical Industries PSC (JULPHAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Gulf Pharmaceutical Industries PSC (Julphar) is a pharmaceutical company that manufactures and distributes medicines in the Middle East and North Africa (MENA) region. The company's product portfolio consists of antibiotics, antiseptics, wound care and biotechnology, women care, adult primar …
  • Osprey Medical Inc (OSP):医療機器:M&Aディール及び事業提携情報
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • MEAG Munich Ergo AssetManagement GmbH:電力:M&Aディール及び事業提携情報
    Summary MEAG Munich Ergo AssetManagement GmbH (MEAG Munich), a subsidiary of Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft (Munich Re) is an asset management company that manages assets of Munich Re and ERGO Insurance Group and its affiliates. The company offers services such as asset …
  • Xtant Medical Holdings Inc (XTNT)-製薬・医療分野:企業M&A・提携分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteow …
  • PCM Inc:戦略・SWOT・企業財務分析
    PCM Inc - Strategy, SWOT and Corporate Finance Report Summary PCM Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • ALK-Abello AS (ALK B):企業の財務・戦略的SWOT分析
    ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Henry Schein, Inc.:企業の戦略・SWOT・財務情報
    Henry Schein, Inc. - Strategy, SWOT and Corporate Finance Report Summary Henry Schein, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Target Corp:企業の戦略・SWOT・財務情報
    Target Corp - Strategy, SWOT and Corporate Finance Report Summary Target Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Arthrex Inc:企業の戦略的SWOT分析
    Arthrex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • PT Perusahaan Gas Negara (Persero) Tbk (PGAS):企業の財務・戦略的SWOT分析
    PT Perusahaan Gas Negara (Persero) Tbk (PGAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆